GROUP ONE TRADING, L.P. - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is and the CUSIP is 92686J906. A total of 4 filers reported holding VIKING THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,831,327
-71.0%
346,100
-57.6%
0.01%
-69.0%
Q2 2023$13,228,981
+12.4%
816,100
+15.4%
0.04%
-2.3%
Q1 2023$11,773,215
+285.3%
707,100
+117.5%
0.04%
+514.3%
Q4 2022$3,055,940
+788.4%
325,100
+157.0%
0.01%
+600.0%
Q3 2022$344,000
-23.2%
126,500
-18.4%
0.00%0.0%
Q2 2022$448,000
-15.9%
155,000
-12.7%
0.00%0.0%
Q1 2022$533,000
-70.3%
177,600
-54.4%
0.00%0.0%
Q4 2021$1,793,000
-60.9%
389,800
-46.6%
0.00%
-80.0%
Q3 2021$4,588,000
+22.3%
730,500
+16.6%
0.01%0.0%
Q2 2021$3,752,000
+26.5%
626,300
+33.6%
0.01%
+25.0%
Q1 2021$2,965,000
+272.0%
468,700
+231.2%
0.00%
+300.0%
Q4 2020$797,000
-57.2%
141,500
-55.8%
0.00%
-83.3%
Q3 2020$1,861,000
-29.2%
319,800
-12.2%
0.01%
-50.0%
Q2 2020$2,627,000
+29.5%
364,400
-16.0%
0.01%
-25.0%
Q1 2020$2,029,000
-9.3%
433,600
+55.4%
0.02%
+6.7%
Q4 2019$2,238,000
+12.1%
279,000
-3.8%
0.02%
-6.2%
Q3 2019$1,996,000
-17.6%
290,100
-0.6%
0.02%
-27.3%
Q2 2019$2,422,000
+2.7%
291,800
+23.0%
0.02%
-15.4%
Q1 2019$2,358,000
+23.8%
237,200
-4.7%
0.03%
+52.9%
Q4 2018$1,904,000
-80.9%
248,900
-56.4%
0.02%
-78.5%
Q3 2018$9,943,000
+313.3%
570,800
+125.2%
0.08%
+276.2%
Q2 2018$2,406,000
+1872.1%
253,500
+805.4%
0.02%
+2000.0%
Q1 2018$122,00028,0000.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 346,100$3,831,3270.01%
SIMPLEX TRADING, LLC 508,000$5,6230.00%
JPMORGAN CHASE & CO 60,000$664,2000.00%
OSAIC HOLDINGS, INC. 2$8600.00%
JANE STREET GROUP, LLC 131,600$1,456,8120.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of VIKING THERAPEUTICS INC shareholders